Physician profile
Thomas A Mustoe
NPI 1952309908
$17,914.06
in general payments reported to CMS, 2019-2025
54 companies · $3,549 in 2025
The $3,549 reported for 2025 was more than what 78% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,758 · 2020: $785 · 2021: $1,010 · 2022: $2,324 · 2023: $3,759 · 2024: $3,729 · 2025: $3,549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $466 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,569.94 |
| Travel and Lodging | $466.08 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,273.88 | 2019-2025 | |
| Medtronic, INC. | $1,230.60 | 2021-2025 | Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan, Micra |
| Novo Nordisk INC | $1,222.33 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $1,177.90 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,147.94 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,078.18 | 2019-2025 | Lifevest |
| Philips North America LLC | $953.68 | 2019-2025 | (5050) Ext Holter, Extended Holter |
| Abbott Laboratories | $844.79 | 2019-2025 | Assurity, Diamondback Coronary, Gallant |
| Penumbra, INC. | $649.50 | 2024 | Indigo System |
| Merck Sharp & Dohme LLC | $634.05 | 2022-2025 | Verquvo, Capvaxive |
| Abiomed | $592.51 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $537.14 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $492.45 | 2019-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $486.92 | 2021-2025 | |
| Pfizer INC. | $459.09 | 2019-2025 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $441.42 | 2019-2025 | Repatha, Repatha |
| Lilly USA, LLC | $426.42 | 2019-2025 | Jardiance |
| Heartflow, INC. | $392.20 | 2019-2022 | |
| Medtronic Vascular, INC. | $378.85 | 2019-2020 | |
| Edwards Lifesciences Corporation | $374.81 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $355.77 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $300.86 | 2021-2025 | Watchman Flx, Watchman Access System, Emblem Mri S-Icd |
| Actelion Pharmaceuticals US, INC. | $246.21 | 2022-2024 | Uptravi, Opsumit |
| Biosense Webster, INC. | $227.69 | 2019-2023 | Carto 3 |
| Biotronik INC. | $214.32 | 2019-2024 | Edora 8 Dr-T, Biomonitor, Amvia Edge |
| Sanofi-Aventis U.S. LLC | $198.85 | 2019-2023 | |
| Cardiovascular Systems INC. | $154.76 | 2019-2023 | Diamondback Coronary |
| Cleerly, INC. | $115.20 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Esperion Therapeutics, INC. | $108.29 | 2022 | |
| Baxter Healthcare | $105.41 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| W. L. Gore & Associates, INC. | $91.90 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $85.43 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $76.10 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Regeneron Healthcare Solutions, INC. | $71.77 | 2019-2023 | Evkeeza |
| Kowa Pharmaceuticals America, INC. | $67.63 | 2019-2020 | |
| Inari Medical, INC. | $63.82 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Irhythm Technologies, INC. | $58.20 | 2024 | Zio Monitor, Zio Xt Patch |
| Siemens Medical Solutions USA, INC. | $57.76 | 2023 | Artis Icono Floor |
| Daiichi Sankyo INC. | $52.67 | 2023-2025 | Injectafer |
| Genzyme Corporation | $50.23 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $48.92 | 2023 | Inpefa |
| Bridgebio Pharma, INC. | $45.36 | 2025 | Attruby |
| Kiniksa Pharmaceuticals, LTD. | $44.17 | 2023 | Arcalyst |
| Lundbeck LLC | $39.94 | 2019 | |
| Alnylam Pharmaceuticals INC. | $37.92 | 2025 | Amvuttra |
| Vifor Pharma, INC. | $35.71 | 2019 | |
| Becton, Dickinson and Company | $29.87 | 2024 | Arista Ah Flexitip |
| Tepha INC | $26.20 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $24.41 | 2019 | |
| Arbor Pharmaceuticals, INC. | $19.67 | 2019 | |
| Ethicon US, LLC | $17.30 | 2025 | Stratafix |
| Atricure, INC. | $16.64 | 2024 | |
| Kestra Medical Technology Services, INC. | $15.77 | 2022 | |
| Inspire Medical Systems, INC. | $14.65 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mustoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.